4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)-
- CAS No.
- 156586-91-3
- Chemical Name:
- 4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)-
- Synonyms
- Xemilofiban hydrochloride
- CBNumber:
- CB13357326
- Molecular Formula:
- C18H22N4O4.ClH
- Molecular Weight:
- 394.85
- MDL Number:
- MOL File:
- 156586-91-3.mol
4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)- Properties
FDA UNII | HIU55WBI80 |
---|
4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)- Chemical Properties,Uses,Production
Originator
Complamin,Doetsch Grether AG
Uses
Prevention of post-recanalization reocclusion of coronary vessels; treatment of unstable angina.
Manufacturing Process
4-Aminobenzamidine dihydrochloride (25.0 g, 120 mmol), was added to dry
DMF (100 ml). To this solution dry pyridine (100 ml) and succinic anhydride
(12.0 g, 120 mmol) followed by dimethylaminopyridine (DMAP 1.5 g 0.012
mmol) were added. The product precipitated after heating for 0.5 h at 100°C,
then was filtered, washed with water, acetonitrile and ether. The light solid
was suspended in dioxane, 4 N HCl in dioxane (100 ml) was added and the
suspension was stirred for 1 h, filtered and dried in a desiccator to give 28.0
g, 88% of 4-[[4-(aminoiminomethyl)phenyl]amino]-4-oxo-butanoic acid
hydrochloride as a white yellow solid, melting point 270-290°C (dec.).
4-[[4-(Aminoiminomethyl)phenyl]amino]-4-oxo-butanoic acid hydrochloride
was added to dry DMF followed by N-methylmorpholine and isobutyl
chloroformate at 25°C. The mixture was stirred for 5 min. Ethyl 3-amino-4-
pentynoate was added followed by di-iso-propylethylamine and a catalytic
amount of dimethylaminopyridine. After 1 h, the solvent was removed under
reduced pressure and the product was purified by reverse phase
chromatography (0.05% TFA water/acetonitrile) and lyophilized to give ethyl
3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-
pentynoate.
By division of stereo-isomers of the ethyl 3-[[4-[[4-(aminoiminomethyl)
phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate on column
chromatography the ethyl (3S)-3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-
1,4-dioxobutyl]amino]-4-pentynoate may be obtained.
Therapeutic Function
Fibrinogen receptor antagonist
4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)- Preparation Products And Raw materials
Raw materials
1of2
Preparation Products
4-Pentynoic acid, 3-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-, ethyl ester, monohydrochloride, (3S)- Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38663 | 58 |
Supplier | Advantage |
---|---|
TargetMol Chemicals Inc. | 58 |